Graham Holdings Company research snapshot
GHC AI stock analysis currently reads Graham Holdings Company as a diversified conglomerate with Kaplan as its largest earnings driver, supplemented by manufacturing, television broadcasting, healthcare, and digital media businesses. At the July 12, 2026 data cutoff, GHC traded near $1,158 with a market capitalization near $4.98 billion. The business quality is adequate but the conglomerate structure makes the GHC AI stock forecast dependent on the performance of individual segments, particularly Kaplan enrollment trends, manufacturing margins, and healthcare regulation. This page is informational research and not investment advice.
Current price
$1,158
Market cap
$4.98 billion
AI score
62 / 100
Rating
Diversified holding company with a strong education franchise in Kaplan, cyclical manufacturing exposure, and a collection of smaller media and healthcare businesses
Trend status
Above the 50-day and 200-day moving averages, with neutral RSI and low volatility relative to the broader market
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Graham Holdings operates a collection of businesses anchored by Kaplan, a leading test preparation and online education provider. The sum has reasonable diversification but none of the segments individually qualify as exceptional. | Medium |
| Moat | Moat is limited to brand recognition in test preparation (Kaplan), local market positions in TV broadcasting (Graham Media Group), and niche manufacturing relationships. No segment has a wide or durable competitive advantage. | Low-medium |
| Management | Timothy O'Shaughnessy has led the company since 2021, overseeing the transition from the Washington Post heritage to a leaner holding company structure. Capital allocation remains conservative. | Medium |
| Financial trend | Q1 2026 revenue was $1.24 billion with net income of $29.1 million and EPS of $16.79, beating analyst estimates by 26.8%. TTM net income through Q1 2026 was approximately $297 million. | High |
| Valuation | At $1,158, financial_rigor.py calculates about 17.1x TTM EPS, 1.16x book value, 6.8% ROE proxy, 0.65% dividend yield, and a free cash flow yield near 7.3%. | High |
| Technical trend | Barchart showed GHC above its 50-day moving average near $1,133 and 200-day moving average near $1,103, with 14-day RSI near 52.9 and 20-day average volume near 22,545 shares. | Medium-high |
| Risk level | Main risks are dependence on Kaplan's competitive position in online education, cyclical exposure to manufacturing and construction, healthcare regulation and reimbursement, low trading liquidity with 20K average daily volume, and the persistent conglomerate discount. | Medium-high |
| AI confidence | High for reported historical data and market math. Medium for forward-looking assessment because GHC's diversified segments make aggregate performance harder to predict than a single-business company. | High data confidence |
| Investment certainty | Medium-low certainty. GHC is not overvalued but the conglomerate structure, limited analyst coverage, thin liquidity, and mixed competitive positions across segments create a wide range of potential outcomes. | Medium-low |
GHC AI stock forecast
The GHC AI stock forecast uses scenario math around the $1,158 quote. A three-year EPS framework using TTM EPS of $67.57 produced a bullish value near $1,799, a base value near $1,252, and a bearish value near $811. The range is wide because Graham Holdings is sensitive to Kaplan enrollment trends, manufacturing demand cycles, healthcare policy, and how investors apply a conglomerate discount to the sum-of-parts value.
$1,680 to $1,850
More likely if Kaplan achieves sustained enrollment growth and margin expansion, manufacturing benefits from a strong construction cycle, healthcare margins stabilize, and the market narrows the conglomerate discount by assigning higher multiples to the education segment.
$1,150 to $1,350
More likely if EPS grows at a mid-single-digit rate, Kaplan holds market share against competitors, manufacturing cycles near trend, and the stock continues to trade at a modest conglomerate discount to sum-of-parts.
$750 to $880
More likely if Kaplan faces competitive pressure from lower-cost online alternatives, manufacturing enters a downturn, healthcare reimbursement tightens, media advertising revenue declines, or the conglomerate discount widens.
GHC AI technical analysis
GHC AI technical analysis shows a stock trading above both its 50-day and 200-day moving averages as of the July 12, 2026 data cutoff. Barchart reported GHC with a 14-day RSI near 52.90, 20-day average volume near 22,545 shares, and 14-day ATR near $35.00. The ADX reading near 9.5 suggests a weak or developing trend rather than a strong directional move.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $1,158 | CompaniesMarketCap share price used for this static page and market cap verification. |
| Near support | $1,133 to $1,150 | The 50-day moving average near $1,133 and the recent trading range define the first support zone. |
| Secondary support | $1,003 to $1,103 | The 200-day moving average near $1,103 and the psychological $1,000 area provide deeper support levels. |
| Near resistance | $1,178 to $1,225 | The recent high near $1,178 and the 52-week high near $1,225 define the resistance band. |
| 50-day SMA | $1,132.73 | Barchart reported GHC trading above the 50-day moving average. |
| 200-day SMA | $1,102.62 | Barchart reported GHC trading above the 200-day moving average. |
| Momentum | 14-day RSI 52.90 | Momentum is neutral, not overbought or oversold by the common 30/70 RSI thresholds. |
| Volume | About 22,545 shares per day | The 20-day average volume is low, meaning large orders can move the stock significantly. |
| Volatility | 14-day ATR $35.00 | Normal daily movement is moderate in percentage terms but can be significant given the thin liquidity profile. |
| Invalidation | Close below $1,133, then $1,103 | A close below the 50-day moving average would weaken the near-term setup. A break below the 200-day moving average would signal broader trend damage. |
GHC AI trading strategy
The GHC AI trading strategy is a rules-based framework for a diversified holding company with low liquidity. It is not personalized advice and should be paired with live chart data, earnings dates, Kaplan enrollment updates, manufacturing indicators, and clear invalidation levels.
Watch for GHC to hold above the 50-day moving average near $1,133 and then clear the $1,178 to $1,225 resistance zone on above-average volume and positive segment news.
A close back below the 50-day moving average, or a failure to break resistance while volume stays below 20-day average, should invalidate the near-term trend setup.
If GHC pulls back toward $1,103 or the $1,000 area without a deterioration in Kaplan enrollment, manufacturing orders, or healthcare margins, compare the price move with the conglomerate sum-of-parts valuation.
Do not use the conglomerate discount argument as a substitute for stop discipline because low-liquidity stocks can gap on unexpected news.
Track Kaplan revenue and enrollment trends, manufacturing segment margins, Graham Media Group advertising revenue, Graham Healthcare Group reimbursement rates, corporate cash and debt levels, and share repurchase activity.
Reduce confidence if Kaplan revenue growth slows for two consecutive quarters, manufacturing margins contract, healthcare regulation changes negatively, or the company increases leverage for acquisitions.
Investment research summary
Graham Holdings is a collection of businesses where Kaplan (education) is the most significant earnings contributor, supported by manufacturing, TV broadcasting, healthcare services, digital media, and automotive dealerships. The company operates as a holding company rather than a single integrated enterprise.
The moat is narrow and mostly confined to the Kaplan brand in test preparation and graduate education. Graham Media Group benefits from local broadcasting regulatory licenses, and the manufacturing businesses have customer relationships, but none of these advantages are wide or durable against determined competitors.
The thesis fails if Kaplan loses share to lower-cost online alternatives, manufacturing enters a prolonged downturn, healthcare margins compress from reimbursement pressure, the company overpays for acquisitions, or the conglomerate discount widens rather than narrows.
Timothy O'Shaughnessy and the management team have maintained a conservative capital allocation strategy with modest leverage and periodic share repurchases. The main question is whether management can create value through active capital deployment rather than simply holding a portfolio of businesses.
Education technology, healthcare services, and manufacturing are all large addressable markets, but each faces structural change. Online education competition is increasing, healthcare reimbursement is under political scrutiny, and manufacturing is cyclical.
At about 17.1x TTM EPS and 1.16x book value, GHC is not expensive on an absolute basis. The margin of safety improves if the stock trades below $1,000 where the conglomerate discount becomes more pronounced relative to sum-of-parts estimates.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| GHC price | $1,158.48 share price used for market cap verification | CompaniesMarketCap | July 12, 2026 |
| Market capitalization | $4.98 billion, verified as $1,158.48 x ~4.30 million shares | CompaniesMarketCap and financial_rigor.py | July 12, 2026 |
| Shares outstanding | ~4.30 million equivalent shares implied by $4.98B market cap at $1,158.48 | CompaniesMarketCap and Google Finance | July 12, 2026 |
| Q1 2026 revenue | $1.24 billion, approximately in line with consensus estimates | Google Finance | July 12, 2026 |
| Q1 2026 net income | $29.1 million net income with EPS of $16.79, beating analyst estimates by 26.8% | Google Finance and earnings report | July 12, 2026 |
| TTM financial summary | TTM revenue approximately $4.99 billion, TTM net income approximately $297 million, TTM EPS $67.57 | Google Finance quarterly data | July 12, 2026 |
| P/E ratio | ~17.1x TTM EPS at $1,158.48 | Google Finance and financial_rigor.py | July 12, 2026 |
| Dividend | Quarterly dividend of $1.88 per share, annual yield approximately 0.65% | Google Finance | July 12, 2026 |
| Valuation math | 17.14x EPS, 1.16x book value, 6.76% ROE proxy, 0.65% dividend yield, and FCF yield near 7.3% | financial_rigor.py valuation verification | July 12, 2026 |
| Technical indicators | 50-day SMA $1,132.73, 200-day SMA $1,102.62, 14-day RSI 52.90, 14-day ATR $35.00 | Barchart technical analysis | July 12, 2026 |
| Three-scenario model | Bullish $1,799, base $1,252, bearish $811 based on financial_rigor.py EPS growth and PE assumptions | financial_rigor.py three-scenario model | July 12, 2026 |
| Beta | 0.72, lower than the broader market, reflecting the conglomerate structure | Google Finance | July 12, 2026 |
This GHC AI stock analysis is an informational tool based on public filings, market data, technical indicators, and scenario math available at the stated data cutoff. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast ranges can be wrong, and Graham Holdings stock can move sharply after earnings, Kaplan enrollment changes, acquisition announcements, or shifts in investor sentiment toward small-cap conglomerates.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
